Last updated: 2026-09-29 21:48:40. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Bausch Health Companies Inc. (BHC) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $5.79, with a market capitalization of $2.16B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $4.33 to $8.00. This page covers its latest market performance, valuation, price trends and company information.
$2.16B | |
$5.74 | |
$34.80 | |
$3.96 | |
$5.77 | |
1.12M | |
3.32M | |
-- | |
$8.00 | |
$4.33 | |
-- | |
-- |
Bausch Health Companies Inc. (BHC) is trading at $5.80 in after-hours trading as of 2026-09-29 21:35:00, up 0.43% ($0.03) from the regular-session close of $5.77.
After-hours trading shows how investors are pricing BHC after the regular session closes. The current after-hours price is near the regular-session close, indicating positive after-hours sentiment.
Over the past seven days, Bausch Health Companies Inc. (BHC) moved from $5.67 to $5.79, representing a gain of 2.19% ($0.12).
The stock traded between $5.54 and $5.93 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.
The average daily volume was 1.71 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 39.9%
BHC is currently trading at $5.79, placing it 39.9% of the way from its 52-week low of $4.33 to its 52-week high of $8.00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 20300 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Bausch Health Companies Inc. (BHC) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.